ImmunoGen Inc. received a commitment worth at least $62 million from Aventis SA, which in turn acquired a large share of ImmunoGen's pipeline as part of an agreement to jointly develop antibody-based cancer products. And the deal could get sweeter from there. (BioWorld Today)
ImmunoGen Inc. received a commitment worth at least $62 million from Aventis SA, which in turn acquired a large share of ImmunoGen's pipeline as part of an agreement to jointly develop antibody-based cancer products. And the deal could get sweeter from there. (BioWorld Today)
Sonus Pharmaceuticals Inc. more than doubled its cash holdings after raising net proceeds of about $13.1 million through the private placement of 3.9 million common shares to new and current institutional investors. (BioWorld Today)
Sonus Pharmaceuticals Inc. more than doubled its cash holdings after raising net proceeds of about $13.1 million through the private placement of 3.9 million common shares to new and current institutional investors. (BioWorld Today)
Capitalizing on a stock surge prompted by Friday's approval of a partnered cancer drug, MGI Pharma Inc. on Monday reported plans to sell 4 million shares. (BioWorld Today)
